跳至主要内容
临床试验/NCT02673229
NCT02673229终止4 期

Comparison of Collagenase Santyl Ointment With Antibiotic Ointment in the Outpatient Care of Minor Partial Thickness Burns

University of Kansas Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年9月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
20
试验地点
1
主要终点
Number of Subjects With at Least 95% Wound Healing

研究概览

简要总结

By doing this study, researchers hope to learn if applying Santyl to the burn during the healing process affects the appearance of the resulting scar.

详细描述

Subjects who have minor, second degree burns may be enrolled in this study. Subjects will receive either Santyl ointment or bacitracin ointment to apply to the burn until it heals. Bandages will be used to keep the burn covered while it heals. Second degree burns generally leave a scar. Once the burn heals, lotion and an appropriate bandage will be used to try to minimize the appearance of a scar.

The study hypothesis is that burns treated with Santyl will have a better scar appearance than burns treated with bacitracin.

Subjects enrolled in this study will make once a week visits to the University of Kansas Medical Center outpatient burn clinic until the burn heals. The burn will be assessed for healing at these visits. Once healed, visits to the clinic will be at 60 & 180 days, up to 6 months. At these visits, the appearance of the scar will be evaluated.

This study was originally funded by Smith and Nephew, but Smith and Nephew is no longer providing support for the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provide written informed consent, which will consist of reading, signing, and dating the informed consent document after the Investigator, sub-Investigator or other designated study staff member has explained the study procedures, risks, and contact information. For subjects not able to provide informed consent (e.g., minors), a parent or legally authorized representative must provide consent. Assent must be provided as required by the Institutional Review Board (IRB).
  • Have one or more acute burns which:
  • are thermal, chemical or electrical in etiology
  • in aggregate cover <10% total body surface area (TBSA)
  • are each equal to or less than 72 hrs old
  • are each no more than deep partial thickness (2nd degree)
  • are not visibly infected
  • Able to take in oral fluids.
  • Able to comply with the requirement for daily dressing changes, or have a caretaker who is able to comply.
  • Willing to make all required study visits.

排除标准

  • Contraindications or hypersensitivity to the use of the test article or their components (e.g., known hypersensitivity to bacitracin).
  • Embedded foreign bodies in the burn wound which cannot be immediately removed.
  • The burned tissue includes or is within 1 cm of the eye or genitalia.
  • Severe perioral burns.
  • Airway involvement or aspiration of hot liquids.
  • Suspicion of physical abuse.
  • Burn wound requires a skin graft.
  • Outpatient management of the burn wound is not appropriate.
  • Participation in another investigational clinical study within thirty (30) days of the Screening Visit.
  • The Investigator may declare any subject ineligible for a valid medical reason. Current or recent (< 6 months) history of severe, unstable, or uncontrolled neurological, cardiovascular, gastrointestinal, hematological, hepatic, and/or renal disease or evidence of other diseases based upon a review of medical history that, in the opinion of the Investigator, would preclude safe subject participation in the study.
  • Test articles are cost-prohibitive for subjects

研究组 & 干预措施

Collagenase Santyl

Active Comparator

Applied topically (2 mm thickness once daily)

干预措施: Collagenase Santyl (Drug)

Bacitracin

Sham Comparator

Applied topically (2 mm thickness) once daily

干预措施: Bacitracin (Drug)

结局指标

主要结局

Number of Subjects With at Least 95% Wound Healing

时间窗: 14 days after treatment

Outcome will be reported as number of subjects with at least 95% wound epithelialization

次要结局

  • Vancouver Scar Scale(90 Days After Treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dhaval Bhavsar

Assistant Professor

University of Kansas Medical Center

研究点 (1)

Loading locations...

相似试验